FrancophonIA/ELRC3.0 huggingface dataset:
English: Binocrit is not approved in the management of anaemia associated with hepatitis C.
Latvian: Binocrit lietošana nav apstiprināta ar C hepatītu saistītas anēmijas ārstēšanai.
English: Administer the dose as per standard protocol.
Latvian: Ar adatas aizsargu neaprīkotas pilnšļirces izmantošana Ievadiet devu, atbilstoši standarta protokolam.
English: Stop using Binocrit if you develop these symptoms and contact your doctor or seek medical attention immediately.
Latvian: Jums rodas šie simptomi, pārtrauciet Binocrit lietošanu un nekavējoties sazinieties ar ārstu vai vērsieties pēc medicīniskas palīdzības.
English: Instructions on how to inject Binocrit yourself
Latvian: Instrukcijas, kā sev injicēt Binocrit
English: Binocrit is used to treat anaemia in adults with a bone marrow disorder that causes a severe disruption in the creation of blood cells (myelodysplastic syndromes).
Latvian: Binocrit tiek lietots anēmijas ārstēšanai pieaugušajiem ar kaulu smadzeņu darbības traucējumiem, kas izraisa asins šūnu veidošanās traucējumus (mielodisplastiskie sindromi).
English: Your doctor will decide how Binocrit will be injected.
Latvian: Jūsu ārsts izlems, kā Jums injicēt Binocrit.
English: Binocrit is indicated for non-iron deficient adults prior to major elective orthopaedic surgery, having a high perceived risk for transfusion complications to reduce exposure to allogeneic blood transfusions.
Latvian: Binocrit ir paredzēts lietošanai pieaugušajiem bez dzelzs deficīta, kuriem ir augsts transfūziju komplikāciju risks pirms plānveida ortopēdiskas operācijas, lai samazinātu alogēnās asins transfūzijas.
English: Binocrit should be administered in order to increase haemoglobin to not greater than 11 g/dL (6.8 mmol/L).
Latvian: Binocrit jāievada, lai hemoglobīna līmenis nepārsniegtu 11 g/dl (6,8 mmol/l).
English: Caution should be exercised with escalation of Binocrit doses in patients with chronic renal failure.
Latvian: Jāievēro piesardzība, palielinot Binocrit devas pacientiem ar hronisku nieru mazspēju.
English: This section contains information on how to give yourself an injection of Binocrit.
Latvian: Šajā apakšpunktā sniegta informācija, kā pašam injicēt Binocrit.
English: Binocrit is used to treat symptomatic anaemia caused by kidney disease:
Latvian: Binocrit lieto, lai ārstētu nieru slimības izraisītu simptomātisku anēmiju
English: Only take one dose of Binocrit from each syringe.
Latvian: No katras šļirces izmantojiet tikai vienu Binocrit devu.
English: How to use Binocrit
Latvian: Kā lietot Binocrit
English: Only one dose of Binocrit from each syringe should be taken.
Latvian: No katras šļirces ir jāpaņem tikai viena Binocrit deva.
English: Alternatively, Binocrit can be administered at an initial dose of 450 IU/kg subcutaneously once weekly.
Latvian: Binocrit sākotnējā deva var būt arī 450 SV/kg subkutāni vienu reizi nedēļā.
English: No evidence exists that indicates that treatment with epoetin alfa alters the metabolism of other medicinal products.
Latvian: Mijiedarbība ar citām zālēm un citi mijiedarbības veidi Nav pierādījumu, kas apstiprinātu, ka alfa epoetīna lietošana ietekmē citu zāļu metabolismu.
English: If the haemoglobin level reaches 15 g/dL (9.38 mmol/L), or higher, during the preoperative period, administration of Binocrit should be stopped and further dosages should not be administered.
Latvian: Ja pirmsoperācijas periodā hemoglobīna līmenis sasniedz 15 g/dl (9,38 mmol/l) vai ir augstāks, Binocrit ordinēšana ir jāpārtrauc.
English: Binocrit should be administered after the completion of the blood donation procedure.
Latvian: Asins nodošanas gadījumā Binocrit ievadāms pēc asins nodošanas procedūras pabeigšanas.
English: Instructions on how to inject yourself with Binocrit can be found at the end of this leaflet.
Latvian: Norādījumi par to, kā pašam veikt Binocrit injekcijas, ir dotas šīs lietošanas instrukcijas beigās.
English: • You may be given iron supplements before and during Binocrit treatment to make it more effective.
Latvian: • Pirms Binocrit terapijas un tās laikā Jums var būt papildus jālieto dzelzs, lai palielinātu Binocrit efektivitāti.
English: Binocrit 1,000 IU/0.5 mL solution for injection in a pre-filled syringe Binocrit 2,000 IU/1 mL solution for injection in a pre-filled syringe Binocrit 3,000 IU/0.3 mL solution for injection in a pre-filled syringe Binocrit 4,000 IU/0.4 mL solution for injection in a pre-filled syringe Binocrit 5,000 IU/0.5 mL solution for injection in a pre-filled syringe Binocrit 6,000 IU/0.6 mL solution for injection in a pre-filled syringe Binocrit 7,000 IU/0.7 mL solution for injection in a pre-filled syringe Binocrit 8,000 IU/0.8 mL solution for injection in a pre-filled syringe Binocrit 9,000 IU/0.9 mL solution for injection in a pre-filled syringe Binocrit 10,000 IU/1 mL solution for injection in a pre-filled syringe Binocrit 20,000 IU/0.5 mL solution for injection in a pre-filled syringe Binocrit 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Binocrit 40,000 IU/1 mL solution for injection in a pre-filled syringe
Latvian: Lietošanas instrukcija: informācija pacientam Binocrit 1 000 SV/0,5 ml šķīdums injekcijām pilnšļircē Binocrit 2 000 SV/1 ml šķīdums injekcijām pilnšļircē Binocrit 3 000 SV/0,3 ml šķīdums injekcijām pilnšļircē Binocrit 4 000 SV/0,4 ml šķīdums injekcijām pilnšļircē Binocrit 5 000 SV/0,5 ml šķīdums injekcijām pilnšļircē Binocrit 6 000 SV/0,6 ml šķīdums injekcijām pilnšļircē Binocrit 7 000 SV/0,7 ml šķīdums injekcijām pilnšļircē Binocrit 8 000 SV/0,8 ml šķīdums injekcijām pilnšļircē Binocrit 9 000 SV/0,9 ml šķīdums injekcijām pilnšļircē Binocrit 10 000 SV/1 ml šķīdums injekcijām pilnšļircē Binocrit 20 000 SV/0,5 ml šķīdums injekcijām pilnšļircē Binocrit 30 000 SV/0,75 ml šķīdums injekcijām pilnšļircē Binocrit 40 000 SV/1 ml šķīdums injekcijām pilnšļircē
English: Binocrit contains less than 1 mmol sodium (23 mg) per dose that is to say essentially “sodium free”.
Latvian: Binocrit satur mazāk par 1 mmol nātrija (23 mg) katrā devā - būtībā tās ir “nātriju nesaturošas”.
English: How to store Binocrit
Latvian: Kā uzglabāt Binocrit
English: Talk to your doctor, pharmacist or nurse before using Binocrit.
Latvian: Pirms Binocrit lietošanas konsultējieties ar ārstu, farmaceitu vai medmāsu.
English: Side effects from an overdose of Binocrit are unlikely.
Latvian: Maz ticams, ka pārāk lielas Binocrit devas injicēšana radīs blakusparādības.
English: 10, A-6250 Kundl, Austria
Latvian: Sandoz GmbH, Biochemiestr. 10, A-6250 Kundl, Austrija
English: Binocrit should be administered in order to increase haemoglobin to not greater than 12 g/dL (7.5 mmol/L).
Latvian: Binocrit jāievada, lai hemoglobīna līmenis nepārsniegtu 12 g/dl (7,5 mmol/l).
English: Once a syringe has been removed from the refrigerator and has reached room temperature (up to 25°C) it must either be used within 3 days or disposed of.
Latvian: Ja šļirce ir izņemta no ledusskapja un uzglabāta istabas temperatūrā (līdz 25°C),
English: - All contraindications associated with autologous blood predonation programmes should be respected in patients being supplemented with Binocrit.
Latvian: - Pacientiem, kuri papildus saņem Binocrit, ir jāņem vērā visas kontrindikācijas, kas saistītas ar autologās asins transfūzijas programmām.
English: If the haemoglobin concentration is increasing by more than 2 g/dL (1.25 mmol/L) per month, or if the haemoglobin concentration level exceeds 12 g/dL (7.5 mmol/L), reduce the Binocrit dose by about 25 to 50%.
Latvian: Ja hemoglobīna koncentrācija paaugstinās vairāk par 2 g/dl (1,25 mmol/l) mēnesī vai ja hemoglobīna koncentrācija pārsniedz 12 g/dl (7,5 mmol/l), Binocrit deva jāsamazina par apmēram 25 līdz 50%.
English: - Patients who develop pure red cell aplasia (PRCA) following treatment with any erythropoietin should not receive Binocrit or any other erythropoietin (see section 4.4).
Latvian: pēc ārstēšanas ar jebkuru eritropoetīnu, nedrīkst saņemt Binocrit vai jebkuru citu eritropoetīnu
English: Binocrit is used to treat anaemia in adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma (bone marrow cancer) who may have a need for a blood transfusion.
Latvian: Binocrit tiek lietots anēmijas ārstēšanai pieaugušajiem, kuriem tiek veikta ķīmijterapija norobežotu audzēju, ļaundabīgu limfomu vai multiplo mielomu (kaulu smadzeņu vēzis) ārstēšanai, asins pārliešana.
English: “Instructions on how to inject Binocrit yourself” can be found at the end of the package leaflet.
Latvian: Norādījumi par to, kā pašam veikt Binocrit injekcijas ir sniegti lietošanas instrukcijas beigās.
English: If the haemoglobin concentration level exceeds 13 g/dL (8.1 mmol/L), discontinue therapy until it falls below 12 g/dL (7.5 mmol/L) and then reinitiate Binocrit therapy at a dose 25% below the previous dose.
Latvian: Ja hemoglobīna koncentrācija pārsniedz 13 g/dl (8,1 mmol/l), terapija ir jāpārtrauc, līdz tā samazinās zem 12 g/dl (7,5 mmol/l), un tad Binocrit terapija jāatsāk ar 25% mazāku devu nekā iepriekš.
English: Patients should be monitored closely to ensure that the lowest approved dose of Binocrit is used to provide adequate control of anaemia and of the symptoms of anaemia.
Latvian: Pacienti uzmanīgi jānovēro, lai pārliecinātos, ka anēmijas un anēmijas simptomu adekvātai kontrolei tiek ievadīta zemākā apstiprinātā Binocrit deva.
English: What you need to know before you use Binocrit
Latvian: Kas Jums jāzina pirms Binocrit lietošanas Nelietojiet Binocrit šādos gadījumos:
English: In paediatric patients with chronic renal failure where intravenous access is routinely available (haemodialysis patients) administration of Binocrit by the intravenous route is preferable.
Latvian: Pediatriskiem pacientiem ar hronisku nieru mazspēju, kuriem pastāvīgi ir ievietots intravenozais katetrs (hemodialīzes pacientiem), vēlams Binocrit ievadīt intravenozi.
English: This medicine contains less than 1 mmol sodium (23 mg) per pre-filled syringe, that is to say essentially “sodium-free”.
Latvian: Palīgvielas Šīs zāles satur mazāk par 1 mmol nātrija (23 mg) katrā pilnšļircē - būtībā tās ir “nātriju nesaturošas”.
English: Binocrit is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF):
Latvian: Binocrit ir paredzēts tādas simptomātiskas anēmijas ārstēšanai, kas saistīta ar hronisku nieru mazspēju
English: In patients with chronic renal failure where intravenous access is routinely available (haemodialysis patients) administration of Binocrit by the intravenous route is preferable.
Latvian: Pacientiem ar hronisku nieru mazspēju, kuriem pastāvīgi ir ievietots intravenozais katetrs (hemodialīzes pacientiem), vēlams Binocrit ievadīt intravenozi.
English: Binocrit contains sodium
Latvian: Binocrit satur nātriju
English: Binocrit should be administered to patients with symptomatic anaemia (e.g. haemoglobin concentration ≤ 10 g/dL (6.2 mmol/L)).
Latvian: Binocrit ir jāievada pacientiem ar simptomātisku anēmiju (piem., hemoglobīna koncentrācija ≤ 10 g/dl
English: Binocrit should be administered to patients with anaemia (e.g. haemoglobin concentration ≤ 10 g/dL (6.2 mmol/L)).
Latvian: Binocrit jāievada pacientiem ar anēmiju (piemēram, hemoglobīna koncentrācija ≤ 10 g/dl
English: Do not shake Binocrit syringes.
Latvian: Binocrit šļirces nedrīkst sakratīt.
English: Where intravenous access is not readily available Binocrit may be administered subcutaneously.
Latvian: Ja pacientam nav ievietots intravenozais katetrs, Binocrit var ievadīt subkutāni.
English: INFORMATION IN BRAILLE Binocrit 8,000 IU/0.8 mL
Latvian: Binocrit 8 000 SV/0,8 ml
English: INFORMATION IN BRAILLE Binocrit 30,000 IU/0.75 mL
Latvian: Binocrit 30 000 SV/0,75 ml
English: Binocrit is one of a group of products that stimulate the production of red blood cells like the human protein erythropoietin does.
Latvian: Īpaša piesardzība, lietojot citas zāles, kas stimulē sarkano asins šūnu produkciju Binocrit pieder zāļu grupai, kas stimulē sarkano asins šūnu produkciju, līdzīgi kā cilvēka proteīns eritropoetīns.
English: If the haemoglobin is rising by more than 2 g/dL (1.25 mmol/L) per month, or if the sustained haemoglobin exceeds 12 g/dL (7.5 mmol/L) reduce the Binocrit dose by 25%.
Latvian: Ja hemoglobīna līmeņa pieaugums mēneša laikā pārsniedz 2 g/dl (1,25 mmol/l) vai ja hemoglobīna līmenis pastāvīgi ir augstāks par 12 g/dl (7,5 mmol/l), Binocrit deva ir jāsamazina par 25%.
English: INFORMATION IN BRAILLE Binocrit 9,000 IU/0.9 mL
Latvian: Binocrit 9 000 SV/0,9 ml
English: Binocrit 9,000 IU/0.9 mL solution for injection in a pre-filled syringe Each syringe contains 0.9 mL of solution for injection.
Latvian: Binocrit 9 000 SV/0,9 ml šķīdums injekcijām pilnšļircē Katrā pilnšļircē ir 0,9 ml šķīduma.
English: Binocrit 8,000 IU/0.8 mL solution for injection in a pre-filled syringe Each syringe contains 0.8 mL of solution for injection.
Latvian: Binocrit 8 000 SV/0,8 ml šķīdums injekcijām pilnšļircē Katrā pilnšļircē ir 0,8 ml šķīduma.
English: INFORMATION IN BRAILLE Binocrit 6,000 IU/0.6 mL
Latvian: Binocrit 6 000 SV/0,6 ml
English: Binocrit 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Each syringe contains 0.75 mL of solution for injection.
Latvian: Binocrit 30 000 SV/0,75 ml šķīdums injekcijām pilnšļircē Katrā pilnšļircē ir 0,75 ml šķīduma.
English: If the patient has developed a severe cutaneous skin reaction such as SJS or TEN due to the use of Binocrit, treatment with Binocrit must not be restarted in this patient at any time.
Latvian: Ja pacientam Binocrit lietošanas dēļ ir radusies smaga ādas reakcija, piemēram, SJS vai TEN,
English: Binocrit 7,000 IU/0.7 mL solution for injection in a pre-filled syringe Each syringe contains 0.7 mL of solution for injection.
Latvian: Binocrit 7 000 SV/0,7 ml šķīdums injekcijām pilnšļircē Katrā pilnšļircē ir 0,7 ml šķīduma.
English: Binocrit 8,000 IU/0.8 mL solution for injection in a pre-filled syringe
Latvian: Binocrit 8 000 SV/0,8 ml šķīdums injekcijām pilnšļircē
English: Binocrit 6,000 IU/0.6 mL solution for injection in a pre-filled syringe Each syringe contains 0.6 mL of solution for injection.
Latvian: Binocrit 6 000 SV/0,6 ml šķīdums injekcijām pilnšļircē Katrā pilnšļircē ir 0,6 ml šķīduma.
English: INFORMATION IN BRAILLE Binocrit 4,000 IU/0.4 mL
Latvian: Binocrit 4 000 SV/0,4 ml
English: Binocrit 9,000 IU/0.9 mL solution for injection in a pre-filled syringe
Latvian: Binocrit 9 000 SV/0,9 ml šķīdums injekcijām pilnšļircē
English: Binocrit 4,000 IU/0.4 mL solution for injection in a pre-filled syringe Each syringe contains 0.4 mL of solution for injection.
Latvian: Binocrit 4 000 SV/0,4 ml šķīdums injekcijām pilnšļircē Katrā pilnšļircē ir 0,4 ml šķīduma.
English: INFORMATION IN BRAILLE Binocrit 5,000 IU/0.5 mL
Latvian: Binocrit 5 000 SV/0,5 ml
English: INFORMATION IN BRAILLE Binocrit 40,000 IU/1 mL
Latvian: Binocrit 40 000 SV/1 ml
English: INFORMATION IN BRAILLE Binocrit 20,000 IU/0.5 mL
Latvian: Binocrit 20 000 SV/0,5 ml
English: INFORMATION IN BRAILLE Binocrit 3,000 IU/0.3 mL
Latvian: Binocrit 3 000 SV/0,3 ml
English: • in severely anaemic adults not yet undergoing dialysis
Latvian: • smagas anēmijas ārstēšanai pacientiem, kuriem vēl netiek veikta dialīze.
English: Binocrit 6,000 IU/0.6 mL solution for injection in a pre-filled syringe
Latvian: Binocrit 6 000 SV/0,6 ml šķīdums injekcijām pilnšļircē
English: Binocrit 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Epoetin alfa
Latvian: Binocrit 30 000 SV/0,75 ml šķīdums injekcijām pilnšļircē
English: Binocrit 7,000 IU/0.7 mL solution for injection in a pre-filled syringe
Latvian: Binocrit 7 000 SV/0,7 ml šķīdums injekcijām pilnšļircē
English: INFORMATION IN BRAILLE Binocrit 1,000 IU/0.5 mL
Latvian: Binocrit 1 000 SV/0,5 ml
English: Binocrit 3,000 IU/0.3 mL solution for injection in a pre-filled syringe Each syringe contains 0.3 mL of solution for injection.
Latvian: Binocrit 3 000 SV/0,3 ml šķīdums injekcijām pilnšļircē Katrā pilnšļircē ir 0,3 ml šķīduma.
English: A pre-filled syringe of 0.8 mL contains 8,000 international units (IU) corresponding to 67.2 micrograms epoetin alfa.
Latvian: 0,8 ml pilnšļirce satur 8 000 starptautiskās vienības (SV), kas atbilst 67,2 mikrogramiem alfa epoetīna.*
English: INFORMATION IN BRAILLE Binocrit 2,000 IU/1 mL
Latvian: Binocrit 2 000 SV/1 ml
English: Binocrit 4,000 IU/0.4 mL solution for injection in a pre-filled syringe
Latvian: Binocrit 4 000 SV/0,4 ml šķīdums injekcijām pilnšļircē
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 7,000 IU/0.7 mL injection
Latvian: ZĀĻU NOSAUKUMS Binocrit 7 000 SV/0,7 ml šķīdums injekcijām pilnšļircē
English: What is in this leaflet What Binocrit is and what it is used for What you need to know before you use Binocrit How to use Binocrit Possible side effects How to store Binocrit Contents of the pack and other information What Binocrit is and what it is used for Binocrit contains the active substance epoetin alfa, a protein that stimulates the bone marrow to produce more red blood cells which carry haemoglobin (a substance that transports oxygen).
Latvian: Binocrit satur aktīvo vielu alfa epoetīnu, proteīnu, kas stimulē kaulu smadzenes ražot vairāk sarkanās asins šūnas, kas transportē hemoglobīnu (viela, kas transportē skābekli).
English: INFORMATION IN BRAILLE Binocrit 10,000 IU/1 mL
Latvian: Binocrit 10 000 SV/1 ml
English: 1 pre-filled syringe of 0.7 mL contains 7,000 international units (IU) corresponding to 58.8 micrograms epoetin alfa.
Latvian: NOSAUKUMS(-I) UN DAUDZUMS(-I) Viena 0,7 ml pilnšļirce satur 7 000 starptautiskās vienības (SV), kas atbilst 58,8 mikrogramiem alfa epoetīna.
English: What Binocrit looks like and contents of the pack Binocrit is presented as a clear, colourless solution for injection in a pre-filled syringe.
Latvian: Binocrit ir dzidrs, bezkrāsains šķīdums injekcijām.
English: Your doctor will monitor your blood pressure regularly while you are using Binocrit.
Latvian: Binocrit terapijas laikā ārsts regulāri kontrolēs Jūsu asinsspiedienu.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 30,000 IU/0.75 mL injection
Latvian: ZĀĻU NOSAUKUMS Binocrit 30 000 SV/0,75 ml šķīdums injekcijām pilnšļircē
English: Binocrit 5,000 IU/0.5 mL solution for injection in a pre-filled syringe Each syringe contains 0.5 mL of solution for injection.
Latvian: Binocrit 5 000 SV/0,5 ml šķīdums injekcijām pilnšļircē Katrā pilnšļircē ir 0,5 ml šķīduma.
English: Binocrit 20,000 IU/0.5 mL solution for injection in a pre-filled syringe Each syringe contains 0.5 mL of solution for injection.
Latvian: Binocrit 20 000 SV/0,5 ml šķīdums injekcijām pilnšļircē Katrā pilnšļircē ir 0,5 ml šķīduma.
English: 1 pre-filled syringe of 0.4 mL 6 pre-filled syringes of 0.4 mL 1 pre-filled syringe of 0.4 mL with a needle safety guard 6 pre-filled syringes of 0.4 mL with a needle safety guard
Latvian: 6 0,4 ml pilnšļirces 1 0,4 ml pilnšļirce ar adatas aizsargu 6 0,4 ml pilnšļirces ar adatas aizsargu
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 8,000 IU/0.8 mL injection
Latvian: ZĀĻU NOSAUKUMS Binocrit 8 000 SV/0,8 ml šķīdums injekcijām pilnšļircē
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 9,000 IU/0.9 mL injection
Latvian: ZĀĻU NOSAUKUMS Binocrit 9 000 SV/0,9 ml šķīdums injekcijām pilnšļircē
English: Binocrit 3,000 IU/0.3 mL solution for injection in a pre-filled syringe
Latvian: Binocrit 3 000 SV/0,3 ml šķīdums injekcijām pilnšļircē
English: Binocrit 1,000 IU/0.5 mL solution for injection in a pre-filled syringe
Latvian: Binocrit 1 000 SV/0,5 ml šķīdums injekcijām pilnšļircē
English: Binocrit 40,000 IU/1 mL solution for injection in a pre-filled syringe Each syringe contains 1 mL of solution for injection.
Latvian: Binocrit 40 000 SV/1 ml šķīdums injekcijām pilnšļircē Katrā pilnšļircē ir 1 ml šķīduma.
English: Binocrit 1,000 IU/0.5 mL solution for injection in a pre-filled syringe Each syringe contains 0.5 mL of solution for injection.
Latvian: Binocrit 1 000 SV/0,5 ml šķīdums injekcijām pilnšļircē Katrā pilnšļircē ir 0,5 ml šķīduma.
English: Binocrit 40,000 IU/1 mL solution for injection in a pre-filled syringe
Latvian: Binocrit 40 000 SV/1 ml šķīdums injekcijām pilnšļircē
English: Binocrit 20,000 IU/0.5 mL solution for injection in a pre-filled syringe
Latvian: Binocrit 20 000 SV/0,5 ml šķīdums injekcijām pilnšļircē
English: 1 pre-filled syringe of 0.8 mL contains 8,000 international units (IU) corresponding to 67.2 micrograms epoetin alfa.
Latvian: NOSAUKUMS(-I) UN DAUDZUMS(-I) Viena 0,8 ml pilnšļirce satur 8 000 starptautiskās vienības (SV), kas atbilst 67,2 mikrogramiem alfa poetīna.
English: Binocrit 5,000 IU/0.5 mL solution for injection in a pre-filled syringe
Latvian: Binocrit 5 000 SV/0,5 ml šķīdums injekcijām pilnšļircē
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 6,000 IU/0.6 mL injection
Latvian: ZĀĻU NOSAUKUMS Binocrit 6 000 SV/0,6 ml šķīdums injekcijām pilnšļircē
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 3,000 IU/0.3 mL injection
Latvian: ZĀĻU NOSAUKUMS Binocrit 3 000 SV/0,3 ml šķīdums injekcijām pilnšļircē
English: Binocrit 2,000 IU/1 mL solution for injection in a pre-filled syringe Each syringe contains 1 mL of solution for injection.
Latvian: Binocrit 2 000 SV/1 ml šķīdums injekcijām pilnšļircē Katrā pilnšļircē ir 1 ml šķīduma.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 4,000 IU/0.4 mL injection
Latvian: ZĀĻU NOSAUKUMS Binocrit 4 000 SV/0,4 ml šķīdums injekcijām pilnšļircē
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 40,000 IU/1 mL injection
Latvian: ZĀĻU NOSAUKUMS Binocrit 40 000 SV/1 ml šķīdums injekcijām pilnšļircē
English: Binocrit 10,000 IU/1 mL solution for injection in a pre-filled syringe Each syringe contains 1 mL of solution for injection.
Latvian: Binocrit 10 000 SV/1 ml šķīdums injekcijām pilnšļircē Katrā pilnšļircē ir 1 ml šķīduma.
English: Binocrit 10,000 IU/1 mL solution for injection in a pre-filled syringe
Latvian: Binocrit 10 000 SV/1 ml šķīdums injekcijām pilnšļircē
English: Congenital, familial and genetic disorders
Latvian: Iedzimtas, pārmantotas un ģenētiskas izcelsmes traucējumi Akūta porfīrija3
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 10,000 IU/1 mL injection
Latvian: ZĀĻU NOSAUKUMS Binocrit 10 000 SV/1 ml šķīdums injekcijām pilnšļircē
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 1,000 IU/0.5 mL injection
Latvian: REĢISTRĀCIJAS APLIECĪBAS NUMURS(-I) Binocrit 1 000 SV/0,5 ml šķīdums injekcijām pilnšļircē
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 2,000 IU/1 mL injection
Latvian: ZĀĻU NOSAUKUMS Binocrit 2 000 SV/1 ml šķīdums injekcijām pilnšļircē
English: Binocrit 2,000 IU/1 mL solution for injection in a pre-filled syringe
Latvian: Binocrit 2 000 SV/1 ml šķīdums injekcijām pilnšļircē
English: 1 pre-filled syringe of 0.3 mL 6 pre-filled syringes of 0.3 mL 1 pre-filled syringe of 0.3 mL with a needle safety guard 6 pre-filled syringes of 0.3 mL with a needle safety guard
Latvian: 6 0,3 ml pilnšļirces 1 0,3 ml pilnšļirce ar adatas aizsargu 6 0,3 ml pilnšļirces ar adatas aizsargu
English: - increased risk of death when administered to achieve a haemoglobin concentration level of 12 g/dL (7.5 mmol/L) in patients with active malignant disease receiving neither chemotherapy nor radiation therapy.
Latvian: - palielināja mirstības risku pacientiem ar aktīvu ļaundabīgu saslimšanu, kuri nesaņēma ne ķīmijterapiju, ne staru terapiju, kad lietošanas mērķis bijis panākt hemoglobīna koncentrācijas līmeni 12 g/dl (7,5 mmol/l).
English: Binocrit 2,000 IU/1 mL solution for injection in a pre-filled syringe Each mL of solution contains 2,000 IU of epoetin alfa* corresponding to 16.8 micrograms per mL
Latvian: Katrs ml šķīduma satur 2 000 SV alfa epoetīna* (epoetin alfa), kas atbilst 16,8 mikrogramiem/ml